Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | HTT | P42858 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 3/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.49 |
| ▸ | F3 | P13726 | 1/20 | 0.46 |
| ▸ | F2 | P00734 | 3/20 | 0.46 |
| ▸ | F10 | P00742 | 3/20 | 0.46 |
| ▸ | MAP1LC3B | Q9GZQ8 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | SRD5A1 | P18405 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3438527 | 1.00 | ALDH1A1 (0.53) | ALDH1A1HTTMAPTHPGDCYP1A2 | |
| SCHEMBL3438181 | 0.89 | ALDH1A1 (0.54) | ALDH1A1HTTMAPTHPGDCYP1A2 | |
| SCHEMBL3438182 | 0.89 | ALDH1A1 (0.54) | ALDH1A1HTTMAPTHPGDCYP1A2 | |
| SCHEMBL3438296 | 0.86 | KMT2A (0.51) | ALDH1A1MAPTCYP1A2KMT2AMAOB | |
| SCHEMBL3438294 | 0.86 | KMT2A (0.51) | ALDH1A1MAPTCYP1A2KMT2AMAOB | |
| SCHEMBL3438517 | 0.83 | NPC1 (0.56) | ALDH1A1MAPTHPGDMEN1KMT2A | |
| SCHEMBL3438518 | 0.83 | NPC1 (0.56) | ALDH1A1MAPTHPGDMEN1KMT2A | |
| SCHEMBL3438480 | 0.80 | ALDH1A1 (0.45) | ALDH1A1HTTMAPTHPGDCYP1A2 | |
| SCHEMBL3437878 | 0.80 | MAP1LC3B (0.48) | ALDH1A1HTTMAPTHPGDCYP1A2 | |
| SCHEMBL3437875 | 0.80 | MAP1LC3B (0.48) | ALDH1A1HTTMAPTHPGDCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7807856-B2 | Process for production of 2-Benzylphenol compound | IHARA CHEMICAL INDUSTRY CO., LTD. (JP) | 2010-10-05 | — | — | US | disclosed |
| US-20080194882-A1 | Process For Production of 2-Benzylphenol Compound | IHARA CHEMICAL INDUSTRY CO., LTD. (JP) | 2008-08-14 | — | — | US | disclosed |
| EP-1810957-A1 | METHOD FOR PRODUCING 2-BENZYLPHENOL COMPOUND | Ihara Chemical Industry Co., Ltd. (JP) | 2007-07-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080194882-A1 | Process For Production of 2-Benzylphenol Compound | CYP1B1, CYP4B1, CYP1A1 | ALDH1A1 1026/4885HTT 2366/4885MAPT 4506/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.